West Pharmaceutical Services traded at $358.24 this Friday July 17th, decreasing $4.20 or 1.16 percent since the previous trading session. Looking back, over the last four weeks, West Pharmaceutical Services lost 9.24 percent. Over the last 12 months, its price rose by 69.87 percent. Looking ahead, we forecast West Pharmaceutical Services to be priced at 350.72 by the end of this quarter and at 329.08 in one year, according to Trading Economics global macro models projections and analysts expectations.
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.